
Active Peptides
Quality and affordability do not have to be opposites — they only appear that way when trust is earned lazily.
Wolf exists because quality and affordability do not have to be opposites — they only appear that way when trust is earned lazily. The peptide market has a serious transparency problem: many budget products offer no meaningful documentation of what is actually in them. Wolf is different, because the safety standard is everything.
Manufactured in China — factually, the world's largest producer of active pharmaceutical ingredients and one of the most technically advanced peptide manufacturing environments on earth — every Wolf batch is verified through independent third-party Certificate of Analysis testing before it enters our inventory. But we go further. Each batch is additionally tested at an accredited laboratory again. Two independent verifications. Two separate labs. One consistent result.
The honest truth is that geography is not a quality indicator — established standards are. The Western pharmaceutical industry sources the majority of its raw active ingredients from Chinese manufacturers. When those manufacturers operate to proper standards and are held accountable through independent testing, the product is reliable. We know, because we test it. Twice.
The Wolf catalog is the widest in our range, because the double-testing protocol is applied across the full research-peptide spectrum — GLP-1 agonists, GH secretagogues, tissue-repair peptides, longevity compounds, nootropics, melanocortin-pathway tools, and the more niche compounds (KPV, SLU-PP-332, Kisspeptin-10) that other tiers often do not carry. Every Wolf vial ships with both the original manufacturer COA and our accredited-lab verification COA — a documentation package that matches the pharmaceutical-grade transparency most budget peptide suppliers explicitly avoid.
China is the world's largest producer of active pharmaceutical ingredients — the Western pharmaceutical industry sources the majority of its APIs from Chinese manufacturers. Geography is not a quality indicator; manufacturing standards and independent verification are. Wolf operates with the same testing rigor applied to pharmaceutical-grade inputs.
Every Wolf batch receives two independent Certificate of Analysis tests — first by the original manufacturer, then again by an accredited third-party laboratory after the product arrives in our inventory. Two separate labs, two independent measurements. If they do not agree, the batch is rejected.
Wolf sits at the most accessible tier. The manufacturing origin allows a lower price point without compromising the analytical verification package — every Wolf vial ships with the same HPLC purity + MS identity COA documentation as our US-made lines. For researchers running larger-scale protocols or cost-sensitive workflows, Wolf provides the documented quality at a lower per-vial cost.
Wolf covers compounds that are niche or absent from our other tiers — KPV (anti-inflammatory fragment), SLU-PP-332 (exercise mimetic), Kisspeptin-10 (HPG-axis research), BAC Water (3ml for reconstitution). Plus the full standard catalog: BPC-157, TB-500, CJC-1295, Ipamorelin, MOTS-c, NAD+, PT-141, DSIP, Epithalon, Retatrutide, and GHK-Cu — all double-tested.
The double-testing COA package meets the documentation standard typical research protocols require. For publications that need specific additional analytical screens (TFA residual, endotoxin, heavy metals, microplastic), FourNines is the appropriate tier; for standard research protocols, Wolf provides HPLC purity + MS identity documentation at a lower cost.
Shop the full collection and find the protocol that fits your research.